Further research is needed to fully elucidate the relationship between MT1-MMP and cognitive impairment, given the strong association between MT1-MMP activation, metabolic dysfunctions, and age-related neurological disorders, and to explore the potential therapeutic implications of targeting MT1-MMP in the context of cognitive aging and other neurological disorders associated with metabolic disorders. This evidence concerns the gene MMP14 and nervous system disorder.